In line with our findings in DLB, multiple VGF peptides were shown to be decreased in CSF from patients with AD, FTD (VGF26–62) or amyotrophic lateral sclerosis (ALS) (VGF398–411). The gene discussed is VGF; the disease is Alzheimer disease.